American Journal of Cardiovascular Drugs
Journal Title
- American Journal of Cardiovascular Drugs
ISSN
- E 1179-187X | P 1175-3277 | 1175-3277 | 1179-187X
Publisher
- Adis International Ltd.
- Springer Nature
Listed on(Coverage)
JCR | 2009-2019 |
SJR | 2002-2019 |
CiteScore | 2011-2019 |
SCIE | 2010-2021 |
CC | 2016-2021 |
SCOPUS | 2017-2020 |
MEDLINE | 2016-2021 |
EMBASE | 2016-2020 |
Aime & Scopes
- The American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures. The journal includes:
/// Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively).
/// Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease.
/// Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
/// Therapy in practice reviews covering optimum management of specific conditions.
/// Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine.
/// Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.